Free tool
FAERS Monitor: Trutakna
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761486 or its brand name (Trutakna, Atacicept-Vymj). Reports on generic versions are filed under their own applications.
Reports
8
Serious
8
100% of reports
Hospitalization
0
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood immunoglobulin g decreased3
- bedridden2
- burning sensation2
- diarrhoea2
- illness2
- inflammation2
- influenza like illness2
- laboratory test abnormal2
- nausea2
- pain2
- petechiae2
- rash2
- renal impairment2
- scar2
- steroid withdrawal syndrome2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
| 2019 | 3 |
| 2026 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,151 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| steroid withdrawal syndrome | 2 | 5160.3 | 1551.4 | 5,791 |
| blood immunoglobulin g decreasedSignal | 3 | 3187.4 | 1301.8 | 6,628 |
| petechiae | 2 | 503.7 | 151.7 | 564 |
| bedridden | 2 | 400.1 | 120.5 | 447 |
| scar | 2 | 307.2 | 92.5 | 343 |
| laboratory test abnormal | 2 | 178.2 | 53.7 | 198 |
| inflammation | 2 | 101.9 | 30.7 | 112 |
| burning sensation | 2 | 75.0 | 22.6 | 82 |
| influenza like illness | 2 | 63.9 | 19.2 | 69 |
| renal impairment | 2 | 62.6 | 18.8 | 68 |
| illness | 2 | 51.0 | 15.4 | 55 |
| rash | 2 | 12.1 | 3.6 | 11 |
| pain | 2 | 8.6 | 2.6 | 7 |
| diarrhoea | 2 | 8.1 | 2.5 | 7 |
| nausea | 2 | 6.6 | 2.0 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.